• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型N,N'-二芳基脲的合成及其作为大麻素-1受体抑制剂的理论研究

Synthesis of New N,N'-Diarylureas and Their Theoretical Study as Cannabinoid-1 Receptor Inhibitors.

作者信息

Tsemperlidou Eirini, Georgiou Nikitas, Tzeli Demeter, Karousis Nikolaos, Varvounis George

机构信息

Laboratory of Organic Chemistry, Department of Chemistry, University of Ioannina, Ioannina, 45110, Greece.

Laboratory of Organic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimioupolis Zografou, Athens, 15784, Greece.

出版信息

Chempluschem. 2025 Aug;90(8):e202500270. doi: 10.1002/cplu.202500270. Epub 2025 Jul 7.

DOI:10.1002/cplu.202500270
PMID:40509977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12352735/
Abstract

A series of new N,N'-diarylureas is reported as potential cannabinoid-1 (CB-1) receptor inhibitors. The synthesis of the new N,N'-diarylureas is achieved from the reaction of two substituted anilines with the aid of triphosgene. One aniline carries a pyrazol-1-yl or 1H-1,2,3-triazolyl or 2H-1,2,3-triazolyl propan-2-one group at position-3, while the other aniline is substituted by fluoro, bromo, methoxy, cyano, morpholino, or 4-methyl-2-nitro groups. All new compounds are investigated through density functional theory calculations, molecular docking, and molecular dynamics simulations, showing a strong ability to bind to the orthosteric pocket of the CB-1 receptor and to the allosteric position when CB1 is in complex with agonist AM841. The binding is comparable to that of the well-known CB-1 inhibitor PSNBAM-1. Especially, 1-{3-[2-(1H-pyrazol-1-yl)acetyl]phenyl}-3-(4-methyl-3-nitrophenyl)urea presents better theoretical results than PSNBAM-1.

摘要

报道了一系列新型N,N'-二芳基脲作为潜在的大麻素-1(CB-1)受体抑制剂。新型N,N'-二芳基脲的合成是通过两种取代苯胺在三光气的辅助下反应实现的。一种苯胺在3位带有吡唑-1-基、1H-1,2,3-三唑基或2H-1,2,3-三唑基丙-2-酮基团,而另一种苯胺被氟、溴、甲氧基、氰基、吗啉基或4-甲基-2-硝基取代。所有新化合物均通过密度泛函理论计算、分子对接和分子动力学模拟进行研究,结果表明它们在CB1与激动剂AM841形成复合物时,具有与CB-1受体的正构口袋和变构位点结合的强大能力。其结合能力与著名的CB-1抑制剂PSNBAM-1相当。特别是,1-{3-[2-(1H-吡唑-1-基)乙酰基]苯基}-3-(4-甲基-3-硝基苯基)脲的理论结果比PSNBAM-1更好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b041/12352735/98f5b10ac357/CPLU-90-e202500270-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b041/12352735/c475f55c3e29/CPLU-90-e202500270-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b041/12352735/7c5b91202002/CPLU-90-e202500270-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b041/12352735/996b132f3551/CPLU-90-e202500270-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b041/12352735/3b1776166ee7/CPLU-90-e202500270-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b041/12352735/003bf7f8d0fc/CPLU-90-e202500270-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b041/12352735/fc6caac83e35/CPLU-90-e202500270-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b041/12352735/98f5b10ac357/CPLU-90-e202500270-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b041/12352735/c475f55c3e29/CPLU-90-e202500270-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b041/12352735/7c5b91202002/CPLU-90-e202500270-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b041/12352735/996b132f3551/CPLU-90-e202500270-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b041/12352735/3b1776166ee7/CPLU-90-e202500270-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b041/12352735/003bf7f8d0fc/CPLU-90-e202500270-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b041/12352735/fc6caac83e35/CPLU-90-e202500270-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b041/12352735/98f5b10ac357/CPLU-90-e202500270-g001.jpg

相似文献

1
Synthesis of New N,N'-Diarylureas and Their Theoretical Study as Cannabinoid-1 Receptor Inhibitors.新型N,N'-二芳基脲的合成及其作为大麻素-1受体抑制剂的理论研究
Chempluschem. 2025 Aug;90(8):e202500270. doi: 10.1002/cplu.202500270. Epub 2025 Jul 7.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
From Bench to Bioactivity: Pyranopyrazole Synthesis, Anticancer, Antimicrobial Efficacy, DFT, Molecular Docking, and Molecular Dynamic Insights.从实验台到生物活性:吡喃并吡唑的合成、抗癌、抗菌功效、密度泛函理论、分子对接及分子动力学见解
Anticancer Agents Med Chem. 2025;25(16):1253-1271. doi: 10.2174/0118715206376210250319053528.
4
Pharmacological characterization of a new synthesis compound with antagonistic action on CB1 receptors: Evidence from the animal experimental model.一种对CB1受体具有拮抗作用的新合成化合物的药理学特性:来自动物实验模型的证据。
Eur J Pharmacol. 2025 Sep 15;1003:177973. doi: 10.1016/j.ejphar.2025.177973. Epub 2025 Jul 18.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Novel pyrazoline-piperazine conjugates as anticancer and antibacterial agents: integrating synthesis, in vitro, QSAR, molecular docking, and MD simulation studies.新型吡唑啉-哌嗪共轭物作为抗癌和抗菌剂:综合合成、体外研究、定量构效关系、分子对接和分子动力学模拟研究
Bioorg Chem. 2025 Aug;163:108703. doi: 10.1016/j.bioorg.2025.108703. Epub 2025 Jun 25.
7
Flavonoids as Promising Akt1 Inhibitors in Cancer Medicine: Insights From Molecular Docking, Dynamics, DFT Calculations, and In Vitro Validation.黄酮类化合物作为癌症医学中颇具潜力的Akt1抑制剂:来自分子对接、动力学、密度泛函理论计算及体外验证的见解
Cancer Rep (Hoboken). 2025 Aug;8(8):e70315. doi: 10.1002/cnr2.70315.
8
Exploitation of novel pyrazolo[3,4-d]pyrimidine scaffold tethered to thiazole as potential EGFR/HER2 dual kinase inhibitor to overcome lapatinib resistant breast cancer: Design, synthesis, in silico docking and molecular dynamic simulation.利用与噻唑相连的新型吡唑并[3,4-d]嘧啶支架作为潜在的EGFR/HER2双激酶抑制剂来克服拉帕替尼耐药性乳腺癌:设计、合成、计算机模拟对接和分子动力学模拟
Bioorg Chem. 2025 Aug;163:108671. doi: 10.1016/j.bioorg.2025.108671. Epub 2025 Jun 3.
9
Optimizing and characterizing 4-methyl substituted pyrazol-3-carboxamides leading to the peripheral cannabinoid 1 receptor inverse agonist TM38837.优化和表征 4-甲基取代的吡唑-3-甲酰胺,得到外周大麻素 1 受体反向激动剂 TM38837。
Bioorg Med Chem Lett. 2024 Jan 15;98:129572. doi: 10.1016/j.bmcl.2023.129572. Epub 2023 Dec 1.
10
Synthesis and characterization of a solvatochromic urea-schiff base derivative: Investigating optical properties, hydrogen bonding effect, copper ion sensing, computational analysis, DNA and β-cyclodextrin interactions.一种溶剂致变色尿素-席夫碱衍生物的合成与表征:研究光学性质、氢键效应、铜离子传感、计算分析、DNA与β-环糊精相互作用
Spectrochim Acta A Mol Biomol Spectrosc. 2025 Nov 5;340:126337. doi: 10.1016/j.saa.2025.126337. Epub 2025 May 4.

本文引用的文献

1
N-Heterocyclic Carbenes: A Benchmark Study on their Singlet-Triplet Energy Gap as a Critical Molecular Descriptor.N-杂环卡宾:关于其单重态-三重态能隙作为关键分子描述符的基准研究。
Chemphyschem. 2025 Jun 23;26(12):e202500012. doi: 10.1002/cphc.202500012. Epub 2025 Apr 11.
2
Design and Synthesis of sEH/HDAC6 Dual-Targeting Inhibitors for the Treatment of Inflammatory Pain.设计和合成 sEH/HDAC6 双重靶向抑制剂治疗炎性疼痛。
J Med Chem. 2024 Aug 8;67(15):12887-12911. doi: 10.1021/acs.jmedchem.4c00847. Epub 2024 Jul 21.
3
Effects of Cannabinoids on Intestinal Motility, Barrier Permeability, and Therapeutic Potential in Gastrointestinal Diseases.
大麻素对胃肠道疾病中肠道动力、屏障通透性的影响及其治疗潜力。
Int J Mol Sci. 2024 Jun 18;25(12):6682. doi: 10.3390/ijms25126682.
4
Research and development of ,'-diarylureas as anti-tumor agents.作为抗肿瘤药物的,'-二芳基脲的研发。 (注:原文中存在不明确的字符表述,可能影响准确理解,此翻译是按照给定原文尽量直译)
RSC Med Chem. 2023 May 9;14(7):1209-1226. doi: 10.1039/d3md00053b. eCollection 2023 Jul 20.
5
Targeting the endocannabinoid system: Structural determinants and molecular mechanism of allosteric modulation.靶向内源性大麻素系统:变构调节的结构决定因素和分子机制。
Drug Discov Today. 2023 Jul;28(7):103615. doi: 10.1016/j.drudis.2023.103615. Epub 2023 May 11.
6
Cannabinoids and Multiple Sclerosis: A Critical Analysis of Therapeutic Potentials and Safety Concerns.大麻素与多发性硬化症:对治疗潜力和安全问题的批判性分析
Pharmaceutics. 2023 Apr 5;15(4):1151. doi: 10.3390/pharmaceutics15041151.
7
Self Cycloaddition of o-Naphthoquinone Nitrosomethide to (±) Spiro{naphthalene(naphthopyranofurazan)}-one Oxide: An Insight into its Formation.邻萘醌亚硝基甲基化物与(±)螺{萘(萘并吡喃并呋喃并氮杂环丁烷)}-1-氧化物的自身环加成反应:对其形成过程的深入研究
Chempluschem. 2022 Dec;87(12):e202200313. doi: 10.1002/cplu.202200313.
8
Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation.大麻素受体 1 拮抗剂染料木黄酮可减轻大麻引起的血管炎症。
Cell. 2022 May 12;185(10):1676-1693.e23. doi: 10.1016/j.cell.2022.04.005. Epub 2022 Apr 29.
9
Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids.大麻素受体 1 变构调节剂的合理设计:Org27569 和 PSNCBAM-1 的杂合体。
Bioorg Med Chem. 2021 Jul 1;41:116215. doi: 10.1016/j.bmc.2021.116215. Epub 2021 May 12.
10
The Cannabinoid CB Receptor in Schizophrenia.精神分裂症中的大麻素 CB 受体。
Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Jun;6(6):646-659. doi: 10.1016/j.bpsc.2020.06.018. Epub 2020 Jul 6.